Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Lines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05715840
What this trial is testing

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Who this might be right for
Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 368
Testing effectiveness (Phase 2)Active Not RecruitingNCT04643379
What this trial is testing

Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT06029270
What this trial is testing

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 156
Not applicableUnknownNCT04740996
What this trial is testing

Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shi Yuankai 30
Large-scale testing (Phase 3)Ended earlyNCT04128696
What this trial is testing

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Neoplasms, Head and Neck
GlaxoSmithKline 315
Testing effectiveness (Phase 2)UnknownNCT03975270
What this trial is testing

Sintilimab in Combination With Nab-paclitaxel in Patients With HNSCC (Head and Neck Squamous Cell Carcinoma )

Who this might be right for
Head and Neck Squamous Cell Cancer
Shengyu Zhou 41
Not applicableLooking for participantsNCT07332845
What this trial is testing

Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With Hamstring Tightness

Who this might be right for
Chronic Neck PainHamstring Muscle TightnessNeck Pain
University of Karachi 156
Large-scale testing (Phase 3)Not Yet RecruitingNCT06501664
What this trial is testing

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Who this might be right for
Esophageal Cancer
Rui-hua Xu, MD, PhD 360
Testing effectiveness (Phase 2)Study completedNCT05909904
What this trial is testing

Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
BeiGene 160
Testing effectiveness (Phase 2)UnknownNCT06259721
What this trial is testing

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00971932
What this trial is testing

Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 33
Large-scale testing (Phase 3)Study completedNCT03748134
What this trial is testing

Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Who this might be right for
Esophageal Squamous Cell Carcinoma
Innovent Biologics (Suzhou) Co. Ltd. 746
Testing effectiveness (Phase 2)Looking for participantsNCT06684600
What this trial is testing

Study of Dalpiciclib Isethionate Plus Pyrotinib Maleate in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 35
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)Looking for participantsNCT06177301
What this trial is testing

Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 266
Testing effectiveness (Phase 2)UnknownNCT05611463
What this trial is testing

Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients

Who this might be right for
Oral Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 25
Testing effectiveness (Phase 2)Study completedNCT03866967
What this trial is testing

Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 130
Testing effectiveness (Phase 2)Study completedNCT03416244
What this trial is testing

Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal CancerOesophageal CancerOesophageal Cancer Metastatic+5 more
AIO-Studien-gGmbH 66
Early research (Phase 1)Study completedNCT03509012
What this trial is testing

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckCarcinoma, Non-Small-Cell LungSmall Cell Lung Carcinoma
AstraZeneca 105
Large-scale testing (Phase 3)Study completedNCT03189719
What this trial is testing

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

Who this might be right for
Esophageal Neoplasms
Merck Sharp & Dohme LLC 749
Next Page